Filters close
Newswise: LJI Discovery Paves the Way for Antivirals Against Ebola Virus and Its Deadly Relatives
Released: 17-Sep-2024 5:05 PM EDT
LJI Discovery Paves the Way for Antivirals Against Ebola Virus and Its Deadly Relatives
La Jolla Institute for Immunology

The new study, led by researchers in the Saphire Lab at LJI, reveals the inner workings of the Ebola virus nucleocapsid. LA JOLLA, CA—At this moment, the world has few tools to combat deadly filoviruses, such as Ebola and Marburg viruses. The only approved vaccine and antibody treatments protect against just one filovirus species.

Newswise: Mount Sinai Expert Available to Discuss Collaborative Partnerships in Global Health
Released: 17-Sep-2024 4:40 PM EDT
Mount Sinai Expert Available to Discuss Collaborative Partnerships in Global Health
Mount Sinai Health System

Renowned expert in building global health partnerships and HIV care to speak at the 2024 Concordia Annual Summit

Newswise: Materials Scientist Egami Describes New World Order for Glasses, Liquids
Released: 17-Sep-2024 4:20 PM EDT
Materials Scientist Egami Describes New World Order for Glasses, Liquids
Oak Ridge National Laboratory

Distinguished materials scientist Takeshi Egami has spent his career revealing the complex atomic structure of metallic glass and other liquids. He studies these materials at the Department of Energy’s Oak Ridge National Laboratory and the University of Tennessee, Knoxville.

Newswise: one-of-the-fastest-ocean-currents-is-remarkably-stable-study-finds-940x529.jpeg
Released: 17-Sep-2024 4:05 PM EDT
One of the World's Fastest Ocean Currents Is Remarkably Stable, Study Finds
University of Miami

New study challenges previous assertions of Gulf Stream slowdown

Released: 17-Sep-2024 4:05 PM EDT
Cheryl James Named Vice President, Chief Human Resources Officer for Loyola Medicine and St. Joseph Health System
Loyola Medicine

Trinity Health has announced the appointment of Cheryl James as Vice President and Regional Chief Human Resources Officer for the Illinois/Indiana Region, which includes Loyola Medicine and St. Joseph Health System, effective July 29.

Newswise: NationalGeographic_2797656.jpg?w=2560&h=1700
Released: 17-Sep-2024 4:05 PM EDT
It's Not Your Life Span You Need to Worry About. It's Your Health Span.
Hevolution Foundation

We’re living much longer than our ancestors, but is that always a good thing? With many people living well into our late 70s or beyond, more of us are also spending a greater portion of our lives—sometimes a decade or more—saddled with physical and mental health conditions that can make it challenging to accomplish the tasks of daily life.

   
Newswise: morimoto970__FitMaxWzk3MCw2NTBd.jpg
Released: 17-Sep-2024 4:05 PM EDT
Northwestern receives $32.4 million to study healthy aging
Hevolution Foundation

Northwestern University has been awarded $32.4 million over five years from the Hevolution Foundation to study proteostasis — the processes by which cells maintain protein health for good overall health and to prevent diseases of protein misfolding. A key goal is to improve the health people experience as they age, particularly in their final years.

   
Newswise: FDA Approval of New Drug Regimen Helps Reduce Risk of Breast Cancer Recurrence for Patients with Early-Stage Disease
Released: 17-Sep-2024 4:05 PM EDT
FDA Approval of New Drug Regimen Helps Reduce Risk of Breast Cancer Recurrence for Patients with Early-Stage Disease
University of California, Los Angeles (UCLA), Health Sciences

Teri Boudreaux was one of more than 5,000 women who joined a clinical trial that was looking at the benefit of adding the targeted therapy drug ribociclib to conventional hormonal therapy for the adjuvant treatment of HR-positive, HER2-negative early-stage breast cancer. I

Newswise: Biopole-SA-2048x742.jpg
Released: 17-Sep-2024 4:05 PM EDT
Vandria Closes Series a Round at CHF28.3m
Hevolution Foundation

Hevolution Foundation and Dolby Family Ventures led Vandria’s Series A closing, bringing the capital to CHF 28.3. With the money, the 2021 EFPL spin-out aims to advance its first in class mitophagy inducer VNA-318 that targets several neurodegenerative indications into clinical development.

     
Released: 17-Sep-2024 4:05 PM EDT
How Targeting 'Zombie Cells' Could Help Extend Healthspan
Hevolution Foundation

What if a drug could help you live a longer, healthier life? Scientists at the University of Connecticut are working on it. In a new study in Cell Metabolism, researchers described how to target specific cells to extend the lifespan and improve the health of mice late in life.

   
Newswise: Mapping Out Matter’s Building Blocks in 3D
Released: 17-Sep-2024 3:30 PM EDT
Mapping Out Matter’s Building Blocks in 3D
Thomas Jefferson National Accelerator Facility

Deep inside what we perceive as solid matter, the landscape is anything but stationary. The interior of the building blocks of the atom’s nucleus — particles called hadrons that most of us would recognize as protons and neutrons — are made up of a seething mixture of interacting quarks and gluons, known collectively as partons. The HadStruc collaboration has now come together to map out these partons and disentangle how they interact to form hadrons. Their latest findings were recently published in the Journal of High Energy Physics.

Released: 17-Sep-2024 3:05 PM EDT
FSU Expert Available to Discuss Impacts of Interest Rate Decision by the Federal Reserve
Florida State University

By: Stephen Stone | Published: September 17, 2024 | 3:08 pm | SHARE: On Wednesday, Americans are primed to see the first reduction in the Federal Reserve’s benchmark interest rate in over four years. The size of the cut is widely expected to be either 0.25 or 0.5 percent.The Fed’s current benchmark rate of 5.25 percent is the highest in 23 years and was set to tame inflation that elevated quickly during the pandemic.

Released: 17-Sep-2024 3:05 PM EDT
Central America Could Play Troubling New Role in Cocaine Trade
Ohio State University

For many decades, the coca plant – the main ingredient in cocaine – has been grown almost exclusively in South America. But a new study shows that nearly half of northern Central America appears to be highly suitable for cultivating this lucrative cash crop.

Newswise: Wistar Institute Researchers Identify Parkinson-related Protein’s Role in Cancer and T Cell Activation
Released: 17-Sep-2024 2:05 PM EDT
Wistar Institute Researchers Identify Parkinson-related Protein’s Role in Cancer and T Cell Activation
Wistar Institute

Wistar scientists have demonstrated the role of Parkin — a protein implicated in Parkinson's disease — in the body’s innate immune response to cancer.

Newswise: Wang, Cook and Uddin Elevated to IEEE Senior Members
Released: 17-Sep-2024 2:05 PM EDT
Wang, Cook and Uddin Elevated to IEEE Senior Members
Oak Ridge National Laboratory

Three transportation researchers at the Department of Energy’s Oak Ridge National Laboratory have been elevated to senior member grade of the Institute of Electrical and Electronics Engineers, or IEEE. Group leader Ross Wang and R&D staff member Adian Cook, both in Applied Research for Mobility Systems, received the honor along with Majbah Uddin, R&D staff member in Transportation Analytics and Decision Sciences.

Newswise: Martin-Lab3-Banner.jpg
Released: 17-Sep-2024 2:05 PM EDT
UM School of Medicine Aims to Accelerate Basic Science Research and Advance Drug Therapies with Newly-Created Department
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, has announced the formation of a new Department of Pharmacology, Physiology and Drug Development, which merges the Department of Physiology and Department of Pharmacology. This new Department aligns the basic science research efforts of both entities with a strong emphasis on the development of new drug therapies.

Newswise: Scientists at The Wistar Institute Clone Several New Anti-Interferon Antibodies - Developing Future Therapeutic Candidates with Broad Application Potential
Released: 17-Sep-2024 2:05 PM EDT
Scientists at The Wistar Institute Clone Several New Anti-Interferon Antibodies - Developing Future Therapeutic Candidates with Broad Application Potential
Wistar Institute

Wistar Institute scientists have successfully isolated and cloned fully human antibodies that can block specific Type-I interferon molecules in vitro; their discovery has an array of potential clinical & research applications, enabling scientists with a new way to investigate the role of specific Type-I interferons in a variety of diseases.

   
Newswise: FSU Researchers Work to Protect Local Springs
Released: 17-Sep-2024 2:05 PM EDT
FSU Researchers Work to Protect Local Springs
Florida State University

Florida State University researchers at the Coastal and Marine Laboratory and the School of Communication are working to educate the public and help clean up Wakulla Springs, thanks to funding from the Florida Legislature.

Newswise: Two Common Surgeries Equally Effective for Treating Blinding Condition of the Eyelid
10-Sep-2024 4:05 PM EDT
Two Common Surgeries Equally Effective for Treating Blinding Condition of the Eyelid
NIH, National Eye Institute (NEI)

Trachomatous trichiasis, a potentially blinding condition where inward-turned eyelashes scratch the front of the eye, can successfully be treated by either of the two most common types of eyelid surgery, according to findings from a large comparison trial funded by the National Institutes of Health.

Released: 17-Sep-2024 1:05 PM EDT
AI Researcher Discusses the New Version of ChatGPT’s Advances in Math and Reasoning
University of Washington

Niloofar Mireshghallah, a UW postdoctoral scholar, discusses why math and reasoning have so challenged artificial intelligence models and what the public should know about OpenAI’s new release.



close
0.146